|
enhanced by Google
|
More Offers: |
lapatinib |
Lapatinib is a cancer medication. Lapatinib is used together with another medicine called capecitabine (Xeloda) to treat a certain type of advanced breast cancer that has spread to other parts of the body. Lapatinib is usually given after ...
aolhealth.com/drugs/lapatinib
Lapatinib (INN) or lapatinib ditosylate (USAN) (Tykerb/Tyverb, GSK) is an orally active chemotherapeutic drug treatment for solid tumours such as breast ...
en.wikipedia.org/wiki/Lapatinib - Similar
Learn about the prescription medication Tykerb (Lapatinib), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
www.rxlist.com/tykerb-drug.htm - Similar
Jun 11, 2009 ... Physician reviewed lapatinib patient information - includes lapatinib description, dosage and directions.
www.drugs.com/mtm/lapatinib.html - Similar
The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation ...
www.cancer.gov/drugdictionary/?CdrID=269659 - Similar
Jun 3, 2006 ... Combining the experimental targeted agent lapatinib with the drug capecitabine delayed the progression of breast cancer for nearly twice as ...
www.cancer.gov/clinicaltrials/results/lapatini... - Similar
Apr 1, 2009 ... GSK submits Tyverb®/Tykerb® (lapatinib) for first-line treatment of metastatic breast cancer in Europe, US.
www.gsk.com/media/pressreleases/2009/2009_pressreleas... - Similar
In this trial, we compared lapatinib plus capecitabine with capecitabine alone ... Conclusions Lapatinib plus capecitabine is superior to capecitabine alone ...
content.nejm.org/cgi/content/abstract/355/26/2733 - Similar
News and project information on the Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours.
www.drugdevelopment-technology.com/projects/lapatinib/ - Similar
Lapatinib may cause liver damage which can be severe or life-threatening. Liver damage can occur as soon as several days or as late as several months after ...
www.nlm.nih.gov/medlineplus/druginfo/meds/a607055.html - Similar
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine ...
www.news-medical.net/news/2007/03/14/22592.aspx - Similar
More Offers: |
lapatinib |
Great! Please tell us what you found most helpful.
We're sorry. Please tell us what went wrong.
|
|